Clifford G Tepper1, Julie H T Dang2, Susan L Stewart3, Dao M Fang4, Kimberly A Wong5, Stephenie Y Liu6, Ryan R Davis6, Doan Y Dao7, Jeffrey P Gregg6, Natalie J Török5, Moon S Chen2. 1. Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, California. 2. Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis, Sacramento, California. 3. Division of Biostatistics, Department of Public Health Sciences, University of California Davis, Sacramento, California. 4. Hmong Cultural Center of Butte County, Oroville, California. 5. Department of Internal Medicine, University of California Davis, Sacramento, California. 6. Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, California. 7. Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
Abstract
BACKGROUND: An exploratory study was performed to determine the prevalence of the patatin-like phospholipase domain-containing protein 3 (PNPLA3) rs78409 [G] allele among the Hmong as a risk factor for nonalcoholic fatty liver disease (NAFLD). NAFLD/nonalcoholic steatohepatitis is the world's most common chronic liver disease and is expected to replace viral hepatitis as the leading cause of cirrhosis and potential precursor to hepatocellular carcinoma (HCC). Of all populations in California, the Hmong experience the highest risk of death from HCC and the highest prevalence of metabolic syndrome risk factors among Asians that predispose them to NAFLD. Here a genetic explanation was sought for the high rates of chronic liver disease among the Hmong. The literature pointed to the PNPLA3 rs738409 [G] allele as a potential genetic culprit. METHODS: Cell-free DNA was isolated from 26 serum samples previously collected in community settings. Quantitative polymerase chain reaction-based single-nucleotide polymorphism (SNP) genotyping was performed with a validated TaqMan SNP genotyping assay, and results were analyzed with TaqMan Genotyper software. RESULTS: The PNPLA3 rs738409 [C>G] variant occurred at a frequency of 0.46 (12 of 26; 95% confidence interval, 0.27-0.67). This carrier rate would rank the Hmong as the third highest population in the 1000 Genomes Project. CONCLUSIONS: Although this small sample size limits the generalizability, the high frequency rates of this allele along with the presence of metabolic syndrome risk factors warrant further studies into the etiology of NAFLD among the Hmong. Cancer 2018;124:1583-9.
BACKGROUND: An exploratory study was performed to determine the prevalence of the patatin-like phospholipase domain-containing protein 3 (PNPLA3) rs78409 [G] allele among the Hmong as a risk factor for nonalcoholic fatty liver disease (NAFLD). NAFLD/nonalcoholic steatohepatitis is the world's most common chronic liver disease and is expected to replace viral hepatitis as the leading cause of cirrhosis and potential precursor to hepatocellular carcinoma (HCC). Of all populations in California, the Hmong experience the highest risk of death from HCC and the highest prevalence of metabolic syndrome risk factors among Asians that predispose them to NAFLD. Here a genetic explanation was sought for the high rates of chronic liver disease among the Hmong. The literature pointed to the PNPLA3 rs738409 [G] allele as a potential genetic culprit. METHODS: Cell-free DNA was isolated from 26 serum samples previously collected in community settings. Quantitative polymerase chain reaction-based single-nucleotide polymorphism (SNP) genotyping was performed with a validated TaqMan SNP genotyping assay, and results were analyzed with TaqMan Genotyper software. RESULTS: The PNPLA3 rs738409 [C>G] variant occurred at a frequency of 0.46 (12 of 26; 95% confidence interval, 0.27-0.67). This carrier rate would rank the Hmong as the third highest population in the 1000 Genomes Project. CONCLUSIONS: Although this small sample size limits the generalizability, the high frequency rates of this allele along with the presence of metabolic syndrome risk factors warrant further studies into the etiology of NAFLD among the Hmong. Cancer 2018;124:1583-9.
Authors: Ruben Hernaez; Jody McLean; Mariana Lazo; Frederick L Brancati; Joel N Hirschhorn; Ingrid B Borecki; Tamara B Harris; Thutrang Nguyen; Ihab R Kamel; Susanne Bonekamp; Mark S Eberhardt; Jeanne M Clark; Wen Hong Linda Kao; Elizabeth K Speliotes Journal: Clin Gastroenterol Hepatol Date: 2013-02-13 Impact factor: 11.382
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis Journal: Nature Date: 2015-10-01 Impact factor: 49.962
Authors: Susan L Stewart; Sandy L Kwong; Christopher L Bowlus; Tung T Nguyen; Annette E Maxwell; Roshan Bastani; Eric W Chak; Moon S Chen Journal: World J Gastroenterol Date: 2016-10-14 Impact factor: 5.742
Authors: Stefan Stender; Julia Kozlitina; Børge G Nordestgaard; Anne Tybjærg-Hansen; Helen H Hobbs; Jonathan C Cohen Journal: Nat Genet Date: 2017-04-24 Impact factor: 38.330
Authors: Timothy Wang; Yu Liu; Duke Letran; Julie Ha Thi Dang; Aaron M Harris; Chin-Shang Li; Moon S Chen; Christopher L Bowlus; Eric Chak Journal: J Community Health Date: 2020-04
Authors: Shirley X Jiang; Roberto Trasolini; Michael Heer; Benjamin Cox; Ciaran Galts; Vladimir Marquez; Eric M Yoshida Journal: Can Liver J Date: 2022-02-04